Can adults have Alström syndrome and be undiagnosed?

Yes, adults can have alstrom syndrome and still be undiagnosed. That may sound surprising for a genetic condition, but it happens for a very understandable reason. Alstrom syndrome often unfolds in stages, and the different parts of it may be treated as separate problems for years before anyone recognises the full pattern.

An adult may have a long history of visual impairment, hearing loss, obesity, insulin resistance, diabetes, fatty liver disease, kidney changes, or heart problems without those pieces ever being connected properly. In rare disease care, delayed diagnosis is not unusual. In alstrom syndrome, it is one of the reasons families often spend years looking for answers.

Alstrom syndrome is rare, and many clinicians will never see a confirmed case in everyday practice. When a condition is uncommon and multisystem, people are often diagnosed one symptom at a time rather than as a whole syndrome. A person may be treated in ophthalmology for retinal disease, in endocrinology for diabetes, in audiology for hearing loss, and elsewhere for kidney or liver issues without anyone putting the full picture together.

This is especially true if early childhood records are incomplete, if symptoms developed gradually, or if the person was never assessed in a genetics pathway when younger. Some adults have been told they have unrelated eye disease, atypical type 2 diabetes, metabolic syndrome, or unexplained hearing loss for years before rare disease testing is even considered.

Adults with undiagnosed alstrom syndrome may already have significant vision loss from cone-rod retinal dystrophy, hearing loss, insulin resistance or type 2 diabetes, weight and metabolic concerns, liver involvement, kidney disease, or a past history of cardiomyopathy. Not every adult has all of these features, but the combination of sensory plus metabolic plus multisystem disease is what should raise suspicion.

One difficulty is that some features are common on their own. Diabetes is common. Hearing loss is common. Vision problems have many causes. Fatty liver is common. But the combination, especially when it starts earlier than expected or clusters unusually, is where rare disease thinking becomes important.

There are several reasons delay happens. Some people were assessed before broad genetic testing was easily available. Some were labelled with another syndrome or with isolated conditions. Some had early symptoms that were severe in one system but subtle elsewhere, which made the overall diagnosis harder to see. Others were never referred to genetics because the clinicians around them were managing the immediate problems without stepping back to ask if there was one explanation linking everything together.

Families often recognise this pattern in hindsight. Once the diagnosis is finally made, old pieces suddenly line up. The eye history makes more sense. The diabetes timeline makes more sense. The hearing pattern makes more sense. The issue is not that the syndrome was impossible to recognise. It is that no one had the full picture at the same time.

Diagnosis in adulthood may happen because a new clinician notices the combination of retinal dystrophy, hearing loss, and metabolic disease and recommends genetic testing. It may happen because a relative is diagnosed. It may happen because more advanced sequencing becomes available. It may also happen when an adult with unexplained multisystem disease reaches a rare disease clinic or inherited retinal disease service that is used to pattern recognition.

Sometimes the trigger is simply a better question. Instead of asking what is causing this one symptom, someone asks whether all of these findings could belong to a single syndrome.

Yes, absolutely. A late diagnosis still matters because it changes follow-up, monitoring, family counselling, and the way risk is understood. Even if vision loss or hearing loss is longstanding, a diagnosis can still prompt better cardiac review, kidney surveillance, liver follow-up, diabetes management, sleep review, and access to genetics support. It can also help explain years of confusing medical history.

For some adults, diagnosis also changes the emotional picture. It may not remove grief or frustration, but it can replace years of uncertainty with something more coherent.

Suspicion should rise when an adult has early-onset or longstanding cone-rod retinal dystrophy or severe visual impairment together with hearing loss, type 2 diabetes or insulin resistance, obesity, liver disease, kidney disease, or a history of cardiomyopathy. The broader and more unusual the multisystem pattern is, the more important it becomes to consider syndromic causes.

The comparison with Bardet-Biedl syndrome and other ciliopathies is also important, because overlap exists. That is why genetic confirmation usually matters. Clinical suspicion opens the door, but ALMS1 testing helps settle the diagnosis.

If alstrom syndrome has not been ruled out clearly, it is reasonable to ask whether referral to genetics, inherited retinal disease services, or a rare disease clinic is appropriate. Adults can ask whether previous testing was broad enough, whether ALMS1 was assessed specifically, and whether their combination of symptoms fits a syndromic pattern rather than unrelated diagnoses.

It is also worth asking for copies of previous ophthalmology, audiology, and metabolic records if possible. In rare disease diagnosis, old records often become newly useful.

A lot of delayed diagnosis becomes visible because patients or families keep noticing that the whole pattern still does not make sense. If someone has been carrying multiple chronic diagnoses that never felt fully explained, it is reasonable to ask again. That is not being difficult. That is often how rare disease eventually gets recognised.